Astrazeneca (AZN) Receivables (2009 - 2026)
Astrazeneca's Receivables came in at $16.16 billion for Q3 2026, up 4.3% from $15.5 billion a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca's Receivables was $16.5 billion, up 18.7% from FY2024.
- Receivables has increased in each of the last nine years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- Going back by year, Receivables was $13.9 billion in FY2024 (+7.5%), $12.93 billion in FY2023 (+13.9%), $11.36 billion in FY2022 (+7.8%) and $10.54 billion in FY2021 (+36.1%).
- The five-year range for quarterly Receivables is $9.55 billion (Q1 2022) to $16.5 billion (Q4 2025).
- Year-over-year, Receivables has increased for 25 consecutive quarters, with growth averaging 13.9% over the last eight quarters.
- Over the past five years, the year-over-year growth in Receivables ranged from 0.1% (Q2 2024) to 41.4% (Q2 2022).
- Business Quant data shows AZN's Receivables at $15.68 billion (Q2 2026), $15.29 billion (Q1 2026) and $16.5 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 2.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.16 Bn |
| Jun 30, 2026 | 15.68 Bn |
| Mar 31, 2026 | 15.29 Bn |
| Dec 31, 2025 | 16.50 Bn |
| Sep 30, 2025 | 15.50 Bn |
| Jun 30, 2025 | 15.23 Bn |
| Mar 31, 2025 | 14.18 Bn |
| Dec 31, 2024 | 13.90 Bn |
| Sep 30, 2024 | 12.79 Bn |
| Jun 30, 2024 | 11.85 Bn |
| Mar 31, 2024 | 11.82 Bn |
| Dec 31, 2023 | 12.93 Bn |
| Sep 30, 2023 | 12.06 Bn |
| Jun 30, 2023 | 11.84 Bn |
| Mar 31, 2023 | 10.97 Bn |
| Dec 31, 2022 | 11.36 Bn |
| Sep 30, 2022 | 10.13 Bn |
| Jun 30, 2022 | 9.79 Bn |
| Mar 31, 2022 | 9.55 Bn |
| Dec 31, 2021 | 10.54 Bn |
API Access
Astrazeneca Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();